Market Tracker

10/20 6:02pm ET

Galena Biopharma Inc (NASDAQ:GALE)

1.83
Data as of Oct 20
 -0.03 / -1.61%
Today’s Change
1.56
Today|||52-Week Range
7.77
-63.10%
Year-to-Date

Today’s Trading

Previous close1.86
Today’s open1.86
Day’s range1.75 - 1.89
Volume980,884
Average volume (3 months)1,902,137
Market cap$219.9M
Dividend yield--
Data as of 3:59pm ET, 10/20/2014

Growth & Valuation

Earnings growth (last year)-51.79%
Earnings growth (this year)+50.08%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales179.86
Price/Book34.58

Competitors

 Today’s
change
Today’s
% change
AMPEAmpio Pharmaceutical...-0.16-3.85%
MRTXMirati Therapeutics ...+0.39+2.34%
CCXIChemoCentryx Inc+0.06+1.14%
NAVBNavidea Biopharmaceu...+0.02+1.43%
Data as of 4:06pm ET, 10/20/2014

Financials

Next reporting dateNovember 17, 2014
EPS forecast (this quarter)-$0.11
Annual revenue (last year)$2.5M
Annual profit (last year)-$76.7M
Net profit margin-3,083.15%

Profile

Sector
Health Technology
Industry
Biotechnology
President &
Chief Executive Officer
Mark W. Schwartz
Secretary, CAO, Finance Director &
Controller
Ryan Dunlap
Corporate headquarters
Portland, Oregon

Forecasts